Teleflex Announces Multiple Clinical and Real-World Evidence Studies to Be Highlighted at the 2024 American Urological Association Annual Meeting
Teleflex Incorporated (TFX)
Last teleflex incorporated earnings: 4/30 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
teleflex.com/usa/investor/index
Company Research
Source: GlobeNewswire
Highlights include two head-to-head randomized clinical trials (RCT) data presentations of UroLift™ System vs. other modalities to treat benign prostatic hyperplasia (BPH) -Additional studies examine post-surgery medication use, rates of hospitalization and adverse events of standard BPH treatments -Teleflex unveils latest advancements in BPH treatment with UroLift™ 2 System with Advanced Tissue Control (ATC) designed to treat all prostate types - WAYNE, Pa., May 01, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies, today announced the presentation of multiple clinical studies at the 2024 American Urological Association Annual Meeting, which is being held in San Antonio, TX, from May 3 – 6, 2024. These studies add to the growing body of clinical evidence around the safety, efficacy and patient experience* with a Prostatic Urethral Lift (PUL) using the UroLift™ System for benign BPH. In addition to the presentation of clinical
Show less
Read more
Impact Snapshot
Event Time:
TFX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TFX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TFX alerts
High impacting Teleflex Incorporated news events
Weekly update
A roundup of the hottest topics
TFX
News
- Teleflex (TFX) is a Top-Ranked Growth Stock: Should You Buy? [Yahoo! Finance]Yahoo! Finance
- Respiratory Care Devices Market is expected to reach a revenue of USD 27.8 Bn by 2033, at 9.0 % CAGR: Dimension Market Research [Yahoo! Finance]Yahoo! Finance
- Teleflex (TFX) Expands Vascular Access Portfolio With New Launch [Yahoo! Finance]Yahoo! Finance
- Teleflex Publishes 2023 Global Impact Report [Yahoo! Finance]Yahoo! Finance
- Teleflex Publishes 2023 Global Impact ReportGlobeNewswire
TFX
Earnings
- 5/2/24 - Beat
TFX
Sec Filings
- 5/9/24 - Form 4
- 5/9/24 - Form 4
- 5/9/24 - Form 4
- TFX's page on the SEC website